News & Updates
Filter by Specialty:
MTX treatment break improves COVID-19 booster response in patients with IMIDs
In individuals with immune-mediated inflammatory diseases (IMIDs*), a 2-week interruption in methotrexate (MTX) treatment led to enhanced COVID-19 booster vaccine response compared with those who continued with MTX treatment, according to findings from the VROOM** study.
MTX treatment break improves COVID-19 booster response in patients with IMIDs
18 Aug 2022
Local failure tied to survival in intermediate-risk PCa after definitive radiotherapy
In men with intermediate- or high-risk prostate cancer (PCa), local failure after definitive radiation therapy (RT) is indicative of survival outcomes, according to a recent study.
Local failure tied to survival in intermediate-risk PCa after definitive radiotherapy
18 Aug 2022
Psychotherapy for alcohol use disorder extends benefit to alcohol-related liver disease
Undergoing psychotherapy for alcohol use disorder (AUD) helps prevent the incidence and progression of alcohol-associated liver disease (ALD), according to a study.
Psychotherapy for alcohol use disorder extends benefit to alcohol-related liver disease
18 Aug 2022
Meta-analysis: “Sunshine vitamin” may brighten mood
Vitamin D is known for its role in bone ossification, and most of this vitamin is made when skin is exposed to sunlight. Recently, a meta-analysis has reported that supplemental vitamin D can help alleviate depressive symptoms in adults.
Meta-analysis: “Sunshine vitamin” may brighten mood
17 Aug 2022
HIV-positive patients tend to receive less cardiovascular care
People living with HIV (PLWH) are less likely to receive preventive cardiovascular (CV) care than non-HIV-infected patients, suggest the results of a study conducted in the same outpatient clinic.
